These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18493655)

  • 21. Establishment of a cell model based on FKBP12 dimerization for screening of FK506-like neurotrophic small molecular compounds.
    Xiao H; Wang LL; Shu CL; Yu M; Li S; Shen BF; Li Y
    J Biomol Screen; 2006 Apr; 11(3):225-35. PubMed ID: 16490780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular recognition mechanism of FK506 binding protein: an all-electron fragment molecular orbital study.
    Nakanishi I; Fedorov DG; Kitaura K
    Proteins; 2007 Jul; 68(1):145-58. PubMed ID: 17387719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.
    Gopalakrishnan R; Kozany C; Gaali S; Kress C; Hoogeland B; Bracher A; Hausch F
    J Med Chem; 2012 May; 55(9):4114-22. PubMed ID: 22455444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulatory domains of CNA have different effects on the inhibition of CN activity by FK506 and CsA.
    Wang HL; Du YW; Xiang BQ; Lin WL; Wei Q
    IUBMB Life; 2007 Jun; 59(6):388-93. PubMed ID: 17613169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equilibrium studies of a fluorescent tacrolimus binding to surfactant protein A.
    Cañadas O; Sáenz A; Orellana G; Casals C
    Anal Biochem; 2005 May; 340(1):57-65. PubMed ID: 15802130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling and synthesis of non-cyclic derivatives of GPI-1046 as potential FKBP ligands with neurotrophic properties.
    Zhao L; Liu H; Wang L; Li S
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4385-90. PubMed ID: 16753298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bifunctional molecule that displays context-dependent cellular activity.
    Braun PD; Barglow KT; Lin YM; Akompong T; Briesewitz R; Ray GT; Haldar K; Wandless TJ
    J Am Chem Soc; 2003 Jun; 125(25):7575-80. PubMed ID: 12812497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fragment-based synthesis and SAR of modified FKBP ligands: influence of different linking on binding affinity.
    Röhrig CH; Loch C; Guan JY; Siegal G; Overhand M
    ChemMedChem; 2007 Jul; 2(7):1054-70. PubMed ID: 17541991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimer formation by FKBP-12: roles for cysteine 23 and phenylalanine 36.
    Schories B; Nelson TE; Sane DC
    J Pept Sci; 2007 Jul; 13(7):475-80. PubMed ID: 17554808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting FKBP isoforms with small-molecule ligands.
    Blackburn EA; Walkinshaw MD
    Curr Opin Pharmacol; 2011 Aug; 11(4):365-71. PubMed ID: 21803654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creating diverse target-binding surfaces on FKBP12: synthesis and evaluation of a rapamycin analogue library.
    Wu X; Wang L; Han Y; Regan N; Li PK; Villalona MA; Hu X; Briesewitz R; Pei D
    ACS Comb Sci; 2011 Sep; 13(5):486-95. PubMed ID: 21766878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The discovery of steroids and other novel FKBP inhibitors using a molecular docking program.
    Burkhard P; Hommel U; Sanner M; Walkinshaw MD
    J Mol Biol; 1999 Apr; 287(5):853-8. PubMed ID: 10222195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of small molecule binding molecules by affinity purification using a specific ligand immobilized on PEGA resin.
    Kuramochi K; Miyano Y; Enomoto Y; Takeuchi R; Ishi K; Takakusagi Y; Saitoh T; Fukudome K; Manita D; Takeda Y; Kobayashi S; Sakaguchi K; Sugawara F
    Bioconjug Chem; 2008 Dec; 19(12):2417-26. PubMed ID: 19035789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the specific binding proteins of bioactive small compound using affinity resins.
    Tanaka A
    Methods Mol Biol; 2009; 577():181-95. PubMed ID: 19718517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP-FRB Interaction and Autophagy.
    Parada CA; de Oliveira IP; Gewehr MCF; Machado-Neto JA; Lima K; Eichler RAS; Lopes LR; Bechara LRG; Ferreira JCB; Festuccia WT; Censoni L; Tersariol ILS; Ferro ES
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocardiopsins: new FKBP12-binding macrolide polyketides from an Australian marine-derived actinomycete, Nocardiopsis sp.
    Raju R; Piggott AM; Conte M; Tnimov Z; Alexandrov K; Capon RJ
    Chemistry; 2010 Mar; 16(10):3194-200. PubMed ID: 20112311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein.
    Becker JW; Rotonda J; Cryan JG; Martin M; Parsons WH; Sinclair PJ; Wiederrecht G; Wong F
    J Med Chem; 1999 Jul; 42(15):2798-804. PubMed ID: 10425089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On-chip fragment-based approach for discovery of high-affinity bivalent inhibitors.
    Miyazaki I; Simizu S; Ishida K; Osada H
    Chembiochem; 2009 Mar; 10(5):838-43. PubMed ID: 19226504
    [No Abstract]   [Full Text] [Related]  

  • 39. Heat capacity changes and hydrophobic interactions in the binding of FK506 and rapamycin to the FK506 binding protein.
    Connelly PR; Thomson JA
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4781-5. PubMed ID: 1375751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the preservation of native inter- and intra-molecular hydrogen bonds in the desolvated FK-binding protein·FK506 complex produced by electrospray ionization.
    Hopper JT; Rawlings A; Afonso JP; Channing D; Layfield R; Oldham NJ
    J Am Soc Mass Spectrom; 2012 Oct; 23(10):1757-67. PubMed ID: 22797884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.